AptaBio Therapeutics Inc
KOSDAQ:293780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AptaBio Therapeutics Inc
KOSDAQ:293780
|
KR |
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
CN |
|
Kshitij Polyline Ltd
NSE:KSHITIJPOL
|
IN |
|
Edifier Technology Co Ltd
SZSE:002351
|
CN |
|
K
|
Kerjaya Prospek Group Bhd
KLSE:KERJAYA
|
MY |
|
Cosco Shipping International (Singapore) Co Ltd
SGX:F83
|
SG |
AptaBio Therapeutics Inc
Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.
Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.